Talphera (TLPH) Non-Current Deffered Revenue (2010 - 2022)

Talphera's (TLPH) quarterly Non-Current Deffered Revenue came in at $1.0 million in Q4 2022, down 9.99% year-on-year from $1.2 million in Q4 2021, and down 2.63% quarter-over-quarter from $1.1 million in Q3 2022.

Talphera (TLPH) Non-Current Deffered Revenue (2010 - 2022) Analysis & Trends

Talphera's Non-Current Deffered Revenue history runs 13 years deep, the most recent figure standing at $1.0 million for Q4 2022.

  • On a quarterly basis, Non-Current Deffered Revenue fell 9.99% year-over-year to $1.0 million in Q4 2022; TTM through Dec 2022 was $1.0 million, a 9.99% decrease from a year earlier, with the FY2022 full-year figure at $1.0 million, down 9.99% from the prior year.
  • Non-Current Deffered Revenue fell to $1.0 million in Q4 2022 per TLPH's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $3.4 million in Q1 2018 and bottomed at $1.0 million in Q4 2022.
  • The 5-year median for Non-Current Deffered Revenue is $2.8 million (2019), against an average of $2.3 million.
  • Across the five-year window, Non-Current Deffered Revenue jumped 1108.61% in 2018 and declined 13.99% in 2022, its largest moves.
  • Year by year, Non-Current Deffered Revenue stood at $3.1 million in 2018, then fell by 10.01% to $2.8 million in 2019, then fell by 2.79% to $2.8 million in 2020, then tumbled by 58.21% to $1.2 million in 2021, then fell by 9.99% to $1.0 million in 2022.
  • Per Business Quant, the three latest TLPH Non-Current Deffered Revenue figures stand at $1.0 million (Q4 2022), $1.1 million (Q3 2022), and $1.1 million (Q2 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Talphera 47.31 Mn 9.48 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 1.04 Mn
Sep 30, 2022 1.06 Mn
Jun 30, 2022 1.09 Mn
Mar 31, 2022 1.12 Mn
Dec 31, 2021 1.15 Mn
Sep 30, 2021 1.24 Mn
Mar 31, 2020 2.75 Mn
Dec 31, 2019 2.83 Mn
Sep 30, 2019 2.91 Mn
Jun 30, 2019 2.99 Mn
Mar 31, 2019 3.07 Mn
Dec 31, 2018 3.15 Mn
Sep 30, 2018 3.23 Mn
Jun 30, 2018 3.31 Mn
Mar 31, 2018 3.38 Mn
Dec 31, 2017 3.46 Mn
Sep 30, 2017 267,000.00
Jun 30, 2017 3.64 Mn
Mar 31, 2017 3.73 Mn
Dec 31, 2016 43,000.00